Search Results 731-740 of 19833 for ast

  1. Lenalidomide For Myelodysplastic Syndrome Refractory To Hypomethylating Agents - Mayo Clinic

    AST (SGOT) and ALT (SGPT) ≤ 3 x ULN. Patient must be disease free of prior malignancies for at least 5 years with exception of currently treated basal cell ...

  2. Auranofin And Sirolimus In Treating Participants With Ovarian Cancer - Mayo Clinic

    ... [AST]) and serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) =< 3 x ULN or SGOT (AST) and SGPT (ALT) =< 5 x ULN is acceptable if ...

  3. A Study of TAS-120 in Patients With Metastatic Breast Cancer - Mayo Clinic

    ... AST and ALT ≤ 5 × ULN;; Total bilirubin ≤ 1.5 × ULN or ≤ 3 × ULN in case of Gilbert's syndrome;; Absolute neutrophil count (ANC) ≥ 1.0 × 10^9/L without ...

  4. Hepatitis C - Doctors and departments - Mayo Clinic

    Aspartate aminotransferase (AST) blood test · Hepatitis C antibody test · Liver biopsy · Liver transplant · MELD (model for end-stage liver disease) score. Show ...

  5. Glioma - Doctors and departments - Mayo Clinic

    ... Ast...rocytoma, Oligodendroglioma, Neurofibromatosis, Glioma, Ependymoma, Spinal cord tumor, Peripheral nerve tumor, Neurofibroma, Plexiform neurofibroma ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    ast biopsy, Breast surgery, Double mastectomy, Prophylactic mastectomy, Breast duct excision, Lymph node biopsy, Breast abscess drainage, Radioactive seed ...

  7. A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma - Mayo Clinic

    AST/SGOT and ALT/SGPT > 2.5x ULN (AST and ALT > 5x ULN in the presence of liver metastases);; Serum creatinine > 1.5x ULN and a calculated or measured ...

  8. PORtopulmonary Hypertension Treatment WIth MaCitentan ─ A RandOmized Clinical Trial

    ALT/AST >= 3 x ULN; Bilirubin >= 3 mg/dL at Screening; Any known factor or disease that might interfere with treatment compliance, study conduct, or ...

  9. A Multi-Center Study Evaluating KTE-X19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia - Mayo Clinic

    Serum ALT/AST ≤ 2.5 x ULN; Total bilirubin ≤ 1.5 x ULN; Cardiac ejection fraction ≥ 50% and no clinically significant ECG findings; Baseline oxygen ...

  10. NEXUS Study: A Study To Test Single And Multiple Doses Of MER511 Given To Adults With Graves' Disease - Mayo Clinic

    * ALT or AST \>1.5 × ULN * Total bilirubin \>1.5 × ULN 16. Estimated glomerular filtration rate (eGFR) \<85 mL/min/1.73 m2 using the Chronic Kidney Disease ...